Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
PHARMACIE LERUTH from Liège, company number BE0423593555, closed financial year 2025 with a result of € -22,919 after tax. For that financial year PHARMACIE LERUTH recorded a gross margin of € 48,645 and equity of € 55,494. Compared with financial year 2024, the result moved from € -10,544 to € -22,919. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 55,494
▼ 29% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -22,919
▼ 117 % more loss than in 2024
Profit after tax over the fiscal year.
€ 8,567
▼ 25% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -7,217.
People and assets in 2025
0.5
▲ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 31,135
▲ 111% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,279
▼ 16% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 174,904
▼ 8% vs 2024
€ 16,294 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.
€ 85,581
▲ 9% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 10,203
▲ 67% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 82,656 | € 49,567 | € 39,871 | € 48,645 | ▲ 22% |
| Profit after taxes | € 15,902 | € 6,265 | € -10,544 | € -22,919 | ▼ € 12,375 |
| Equity | € 103,693 | € 88,958 | € 78,413 | € 55,494 | ▼ 29% |
| Total debts | € 325,155 | € 293,349 | € 275,777 | € 271,133 | ▼ 2% |
| Cash | € 24,634 | € 8,861 | € 11,436 | € 8,567 | ▼ 25% |
| Land & buildings | € 175,526 | € 162,525 | € 151,161 | € 137,982 | ▼ 9% |
| Retained profit | € 40,982 | € 26,247 | € 15,703 | € -7,217 | ▼ € 22,919 |
| Dividend | € 0 | € 21,000 | € 0 | € 0 | |
| Bank debt | € 233,589 | € 212,388 | € 190,895 | € 174,904 | ▼ 8% |
| Balance sheet total | € 428,848 | € 382,307 | € 354,190 | € 326,627 | ▼ 8% |
| Employees (FTE) | 0.5 | - | 0.3 | 0.5 | ▲ 0.2 |
Key figures of PHARMACIE LERUTH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE LERUTH?
What happened at PHARMACIE LERUTH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Christiane GREIN stepped down as director. NBB
- Christel LERUTH stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 22,919. Source: NBB ↗
- Christiane GREIN became a director. NBB
- Christel LERUTH became a director. NBB
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 15,902 profit in 2022 to € 22,919 loss in 2025.
Paid € 12,012 in corporate taxes since 2022.
Best year ever: 2022, with € 15,902 profit.
Paid out € 21,000 in dividends to the owners in total.
A new publication or filing at PHARMACIE LERUTH? We notify you, reason included.
Follow PHARMACIE LERUTHDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Christiane GREIN
Director
since 2023 · until 2029
Christel LERUTH
Managing director
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Place Henri-Simon 18
4000 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0423.593.555
- VAT number
- BE 0423.593.555
- Registered office
- Place Henri-Simon 18, 4000 Liège
- Names & denominations
- PHARMACIE LERUTH
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 February 1983
- Peppol
- Active · Active since 4 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers